What does hostile takeover mean?
A takeover is hostile when the acquirer pursues control of a company over the objection of its board of directors. The acquirer does not negotiate a merger agreement; it goes around the board to the shareholders themselves.
Two mechanisms make that possible. The tender offer puts a public bid in front of every shareholder: sell your shares to us at a premium by this date. If enough shares are tendered, the acquirer takes control regardless of what the board thinks. The proxy fight works through corporate democracy instead: the acquirer solicits shareholder votes to replace the incumbent directors with a slate willing to approve the sale. Campaigns often combine both, with the tender offer supplying pressure and the proxy threat supplying the endgame.
The word hostile describes the board’s posture, not the tone of the letters. Some of the most consequential takeovers in market history began hostile and ended as negotiated deals once the board concluded resistance was destroying more value than a sale.
How do boards defend against hostile takeovers?
The defense toolkit built up over four decades of takeover battles. The shareholder rights plan, universally called the poison pill, lets every shareholder except the acquirer buy discounted stock once the acquirer crosses a trigger threshold, typically 10 to 20 percent, diluting the stake so severely that crossing the line becomes economically irrational. Twitter’s board adopted one in April 2022 within days of Elon Musk’s unsolicited offer, before ultimately negotiating the sale. Staggered boards slow proxy fights by putting only a third of directors up for election each year, so control of the board takes two annual meetings to flip. White knight defenses bring in a friendlier acquirer at a better price. Litigation buys time. And state anti-takeover statutes add friction on top.
Notice what every one of these defenses assumes: a public float, an open market for the shares, and a shareholder base the acquirer can reach. Remove those and the entire machinery has nothing to grip.
Why can’t a private company be taken hostile?
Because there is nothing to buy without the owners’ consent. In a founder-controlled company the shares sit with the founder, perhaps family, employees, and a small number of investors, usually subject to transfer restrictions in the shareholder agreement. There is no open market to accumulate a stake in, no tender offer to run, no dispersed base to out-vote the owner. Control changes hands in exactly one way: the owners decide to sell.
That structural immunity is worth stating plainly because founders sometimes hear takeover vocabulary and import public-company fear into a private-company situation. A competitor cannot buy you against your will. A private equity firm cannot accumulate your shares quietly. The control premium in a private sale exists precisely because the buyer must persuade, and pay, the person who holds all the cards. The founder’s leverage problem is never forced sale; it is selling voluntarily but badly.
What founders actually face: the unsolicited approach
The private-company cousin of the hostile bid is the unsolicited approach: a competitor, a sponsor, or a platform company calls with interest in acquiring the business. Nothing hostile about it, but it shares one feature with the tender offer, which is that the buyer chose the timing. The party that initiates has usually studied the market, has a price ceiling in mind, and benefits from the founder having no competing alternative on the table.
Negotiating one-on-one with the party that approached is the standard failure mode, and it has a measurable cost: the discount serial acquirers achieve in unbanked bilateral negotiations against what the same business clears in a competitive process. The correction is process. Interest from one credible buyer is evidence of interest from others, and the approach converts into leverage only when alternatives are actually assembled. The firm’s guide to handling an approach from a sponsor, what to do when private equity approaches you, walks through that conversion, and the broader mechanics live in the firm’s sell-side process playbook.
Questions founders ask
What is a hostile takeover?
An attempt to acquire a company without the support of its board, executed by tender offer directly to shareholders or by proxy fight to replace the directors. The board’s opposition is what makes it hostile.
How do companies defend against hostile takeovers?
Poison pills that dilute any acquirer crossing an ownership threshold, staggered boards that slow proxy fights, white knight sales to a preferred buyer, and litigation. Twitter’s 2022 poison pill in response to Musk’s offer is the recent reference case.
Can a private company be taken over in a hostile takeover?
Effectively no. Without a public float there are no shares to accumulate and no tender offer to run. Control of a founder-held company changes hands only when the owners sell.
What should a founder do about an unsolicited acquisition approach?
Treat it as an information asymmetry problem. The approaching buyer picked the timing and knows the market. Converting the approach into a competitive process, before engaging on price, is what restores leverage.
Published August 25, 2026 by Jeff Barrington, Founder and Managing Director, Windsor Drake. Content on this page may be cited with attribution and a link to https://windsordrake.com/what-is-a-hostile-takeover/